| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/07/2001 | CA2401022A1 Methods for treating fsh related conditions with gnrh antagonists |
| 09/07/2001 | CA2400679A1 Human schizophrenia gene |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/07/2001 | CA2397694A1 Farnesyl protein transferase inhibitor combinations |
| 09/07/2001 | CA2397690A1 Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives |
| 09/07/2001 | CA2397475A1 Farnesyl protein transferase inhibitor combinations with vinca alkaloids |
| 09/07/2001 | CA2397448A1 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
| 09/07/2001 | CA2397446A1 Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents |
| 09/07/2001 | CA2397349A1 Farnesyl protein transferase inhibitor combinations with an her2 antibody |
| 09/07/2001 | CA2397256A1 Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
| 09/07/2001 | CA2397253A1 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| 09/07/2001 | CA2370741A1 Method for detecting and killing epithelial cancer cells |
| 09/07/2001 | CA2339676A1 Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection |
| 09/06/2001 | US20010020036 Synergistic mixtures |
| 09/06/2001 | US20010020034 Isothiazole derivatives useful as anticancer agents |
| 09/06/2001 | US20010020025 Mixture of antiserotonine compound with laxative; therapy for constipation |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | US20010020005 Administering a gastrin inhibitor |
| 09/06/2001 | US20010020002 Androgen activity antagonists as therapies for anorexia, anorexia nervosa and disorders characterized by a pathologically underweight condition |
| 09/06/2001 | US20010019722 Multilayer; sustained release |
| 09/06/2001 | US20010019715 Administering a cytotoxic T-lymphocyte and one agent capable of neutralizing or down regulating the activity of tumor secreted immunosuppressive factors |
| 09/06/2001 | US20010018916 Process and device for inhalation of particulate medicaments |
| 09/06/2001 | DE10107360A1 Novel metalloprotease containing a thrombospondin domain (MPTS protein) is useful to treat aggrecan associated disease including rheumatoid arthritis and osteoarthritis |
| 09/06/2001 | DE10009423A1 Cosmetic or pharmaceutical preparation especially for treatment of cellulite comprises nerve fibre stimulator or depolariser, phosphodiesterase inhibitor and antiestrogen |
| 09/06/2001 | DE10006889A1 Verwendung von Inhibitoren von Caspase-3 oder der Caspase-aktivierten Desoxyribonuclease (CAD) zur Behandlung von Herzerkrankungen Use of inhibitors of caspase-3 or caspase-activated deoxyribonuclease (CAD) for the treatment of heart disease |
| 09/05/2001 | EP1130394A1 In vitro models of CNS function and dysfunction |
| 09/05/2001 | EP1130123A2 Diagnostic method |
| 09/05/2001 | EP1130122A2 Methods for the diagnosis of polymorphisms in the human EP1-R gene |
| 09/05/2001 | EP1130098A2 Mammalian osteoregulins |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1129706A2 Use of cGMP PDE5 inhibitors for the treatment of neuropathy |
| 09/05/2001 | EP1129694A1 Use of components for modifying physico-chemical properties of the skin and/or the mucosal tissue as adhesion prevention/decreasing adhesion agents for microorganisms |
| 09/05/2001 | EP1129351A2 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-$g(a) MEDIATED PATHWAY |
| 09/05/2001 | EP1129350A1 Methods for identifying modulators of bs69 activity |
| 09/05/2001 | EP1129217A2 Compositions and methods of disease diagnosis and therapy |
| 09/05/2001 | EP1129213A1 Bacillus strain and assay methods |
| 09/05/2001 | EP1129212A1 Screening process for antibacterial agents |
| 09/05/2001 | EP1129199A2 Cell signaling polypeptides and nucleic acids |
| 09/05/2001 | EP1129197A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 09/05/2001 | EP1129191A1 Methods of diagnosing or treating neurological diseases |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129188A1 Pge synthase and methods and means for modulating its activity |
| 09/05/2001 | EP1129181A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 09/05/2001 | EP1129119A2 Silane copolymer coatings |
| 09/05/2001 | EP1129110A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 09/05/2001 | EP1129094A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 09/05/2001 | EP1128845A1 Combinations comprising a beta-agonist and a further antdiabetic agent |
| 09/05/2001 | EP1128844A1 Methods for enhancing wound healing |
| 09/05/2001 | EP1128833A1 Use of agonists of glucocorticosteroid receptors and/or mineral corticosteroid receptors, especially corticosteroids to treat addictions |
| 09/05/2001 | EP1128827A1 Pharmaceutical composition for modified release insulin sensitiser |
| 09/05/2001 | EP1128826A1 Chromone enteric release formulation |
| 09/05/2001 | EP1128823A1 Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis |
| 09/05/2001 | EP1128820A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 09/05/2001 | EP1128814A1 Aerosols comprising nanoparticle drugs |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1128811A1 Drug delivery device, especially for the delivery of progestins and estrogens |
| 09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/05/2001 | EP1128727A1 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 09/05/2001 | EP1128725A1 Disposable premoistened wipe containing an antimicrobial protease inhibitor |
| 09/05/2001 | EP1059889A4 Treatment of brain edema using carbonic anhydrase enzyme inhibitor |
| 09/05/2001 | EP1028705B1 Uses of d-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells |
| 09/05/2001 | EP0731708B1 Extract from the leaves of ginkgo biloba |
| 09/05/2001 | CN1311777A High affinity ligands for nociceptin receptor ORL-1 |
| 09/05/2001 | CN1311687A Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 09/05/2001 | CN1311686A Pulmonary delivery of active agents |
| 09/05/2001 | CN1311681A combination therepy for treatment of refractory depression |
| 09/05/2001 | CN1311679A Benzimidazole derivatives as modulators of IgE |
| 09/05/2001 | CN1311675A Compounds having IgE affecting properties |
| 09/05/2001 | CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid |
| 09/05/2001 | CN1311670A Cholinergic agents in the treatment of presbyopia |
| 09/05/2001 | CN1311665A Novel analgesic, anti-inflammatory and wound healing agent |
| 09/05/2001 | CN1070364C Cosmetic or skin-care composition of emulsion of oil covered with water formed with oil drops covered with liquid |
| 09/04/2001 | US6284882 Myostatin gene promoter and inhibition of activation thereof |
| 09/04/2001 | US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases |
| 09/04/2001 | US6284804 Intended for application to the eye, ear or nose |
| 09/04/2001 | US6284797 Capsaicin; norepinephrine inhibitor and a vasodilator which act to promote blood circulation in the treatment area |
| 09/04/2001 | US6284790 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same |
| 09/04/2001 | US6284788 Use of known agonists of the central cannabinoid receptor CB1 |
| 09/04/2001 | US6284781 Anticancer agent |
| 09/04/2001 | US6284778 Neurotrophic agent |
| 09/04/2001 | US6284776 Method for treating diseased-related or drug-induced dyskinesias |
| 09/04/2001 | US6284770 Administering serotonine receptor antagonist |
| 09/04/2001 | US6284767 Retroviral protease inhibiting compounds |
| 09/04/2001 | US6284763 Administering low dosage of antipressor agent |
| 09/04/2001 | US6284751 Carpal tunnel syndrome; adult respiatory suystem disorders; antitumor agents |
| 09/04/2001 | US6284749 Mixture of fungicide with chelate compound |
| 09/04/2001 | US6284730 Administering parathyroid hormone |
| 09/04/2001 | US6284725 Administering binding compound for glucagon receptor such asglucagon-like peptide |
| 09/04/2001 | US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof |
| 09/04/2001 | US6284452 Administering aqueous solution containing potassium, magnesium, sodium, calcium, chloride, oncotic agent, carboxylic acid or salt, sugar and clotting factor |
| 09/04/2001 | US6284289 Treatment of herpes infection with composition containing quaternary ammonium compound and an anti-viral agent |
| 09/04/2001 | US6284287 For administering drugs by breathing |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284263 Buccal drug administration in the treatment of female sexual dysfunction |
| 09/04/2001 | US6284257 Cosmetic water emulsion containing at least one vegetable oil |
| 09/04/2001 | CA2050298C Dry powder inhalation device |
| 09/04/2001 | CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 08/30/2001 | WO2001063267A1 Method of screening compounds for biological activity |
| 08/30/2001 | WO2001063244A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |